drugset / Trial / NCT03201848
The Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia
Phase 4
Unknown
216 enrolled
Qidong Gaitianli Medicines Co., Ltd
Huazhong University of Science and Technology · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multisite, double-blind, randomized, placebo-controlled, and parallel study designed to evaluate the clinical efficacy and safety of Huaiqihuang granule for treatment to children with chronic primary immune thrombocytopenia (Qi Yin deficiency).
Timeline
- Start
- 2017-11-16
- Primary completion
- 2023-10-14
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huaiqihuang Granule | Unknown | — | — |